Trials / Completed
CompletedNCT04124081
Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects
Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects(Single Center, Single Arm, Open, Self - Control)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This study, by comparing the Hydronidone capsules and entecavir capsule in a single dose and steady-state dosing state of both the level of blood drug concentration, assess Hydronidone capsules and entecavir capsule for interaction。
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydronidone capsules& Entecavir capsules | take the Hydronidone capsule and then the entecavir capsule, and then take the last two together |
Timeline
- Start date
- 2019-05-15
- Primary completion
- 2019-06-15
- Completion
- 2019-08-13
- First posted
- 2019-10-11
- Last updated
- 2019-10-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04124081. Inclusion in this directory is not an endorsement.